Related references
Note: Only part of the references are listed.Immunostaining for Polycomb Group Protein EZH2 and Senescent Marker p16INK4a May Be Useful to Differentiate Cholangiolocellular Carcinoma From Ductular Reaction and Bile Duct Adenoma
Motoko Sasaki et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2014)
Targeting histone methyltransferase EZH2 as cancer treatment
Yutaka Kondo
JOURNAL OF BIOCHEMISTRY (2014)
Activated hedgehog pathway is a potential target for pharmacological intervention in biliary tract cancer
Tobias Kiesslich et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2014)
Selective Inhibition of EZH2 by EPZ-6438 Leads to Potent Antitumor Activity in EZH2-Mutant Non-Hodgkin Lymphoma
Sarah K. Knutson et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Self-renewal as a therapeutic target in human colorectal cancer
Antonija Kreso et al.
NATURE MEDICINE (2014)
L07.04 * PRECLINICAL CHARACTERIZATION OF E7438, A POTENT, SELECTIVE EZH2 INHIBITOR WITH ROBUST ANTITUMOR ACTIVITY AGAINST EZH2 MUTATED NHL XENOGRAFTS IN MICE
H. Keilhack
ANNALS OF ONCOLOGY (2013)
Enhancer of Zeste Homolog 2 (EZH2) Promotes Progression of Cholangiocarcinoma Cells by Regulating Cell Cycle and Apoptosis
Shigeki Nakagawa et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
Aberrant DNA Methylation at Genes Associated with a Stem Cell-like Phenotype in Cholangiocarcinoma Tumors
Ruethairat Sriraksa et al.
CANCER PREVENTION RESEARCH (2013)
Roles of histone methyl-modifying enzymes in development and progression of cancer
Takeshi Suzuki et al.
CANCER SCIENCE (2013)
Dysregulation of the Repressive H3K27 Trimethylation Mark in Head and Neck Squamous Cell Carcinoma Contributes to Dysregulated Squamous Differentiation
Orla M. Gannon et al.
CLINICAL CANCER RESEARCH (2013)
Modulation of Epigenetic Targets for Anticancer Therapy: Clinicopathological Relevance, Structural Data and Drug Discovery Perspectives
Federico Andreoli et al.
CURRENT PHARMACEUTICAL DESIGN (2013)
Pathogenesis, Diagnosis, and Management of Cholangiocarcinoma
Sumera Rizvi et al.
GASTROENTEROLOGY (2013)
Inhibition of PRC2 histone methyltransferase activity increases TRAIL-mediated apoptosis sensitivity in human colon cancer cells
Yannick D. Benoit et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2013)
Inhibition of EZH2 suppresses self-renewal and induces radiation sensitivity in atypical rhabdoid teratoid tumor cells
Irina Alimova et al.
NEURO-ONCOLOGY (2013)
Bmi1 Enhances Tumorigenicity and Cancer Stem Cell Function in Pancreatic Adenocarcinoma
Erica Proctor et al.
PLOS ONE (2013)
Noncoding RNA and Polycomb recruitment
Neil Brockdorff
RNA (2013)
Brief Report: The lincRNA Hotair Is Required for Epithelial-to-Mesenchymal Transition and Stemness Maintenance of Cancer Cell Lines
Cleidson Padua Alves et al.
STEM CELLS (2013)
Update of research on the role of EZH2 in cancer progression
Liang Shen et al.
ONCOTARGETS AND THERAPY (2013)
The role of EZH2 in tumour progression
C-J Chang et al.
BRITISH JOURNAL OF CANCER (2012)
EZH2 inhibition: targeting the crossroad of tumor invasion and angiogenesis
Francesco Crea et al.
CANCER AND METASTASIS REVIEWS (2012)
Polycomb in Stem Cells: PRC1 Branches Out
Nuno Miguel Luis et al.
CELL STEM CELL (2012)
TP53 Genomic Status Regulates Sensitivity of Gastric Cancer Cells to the Histone Methylation Inhibitor 3-Deazaneplanocin A (DZNep)
Lai Ling Cheng et al.
CLINICAL CANCER RESEARCH (2012)
Current Status of Therapeutic Targeting of Developmental Signalling Pathways in Oncology
Tobias Kiesslich et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2012)
PRC2 during vertebrate organogenesis: A complex in transition
Issam Aldiri et al.
DEVELOPMENTAL BIOLOGY (2012)
Advances in targeting the Hedgehog signaling pathway in cancer therapy
Tobias Kiesslich et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2012)
EZH2 Methyltransferase and H3K27 Methylation in Breast Cancer
Kyung Hyun Yoo et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2012)
3-Deazaneplanocin A is a promising therapeutic agent for the eradication of tumor-initiating hepatocellular carcinoma cells
Tetsuhiro Chiba et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
PCGF Homologs, CBX Proteins, and RYBP Define Functionally Distinct PRC1 Family Complexes
Zhonghua Gao et al.
MOLECULAR CELL (2012)
The developing cancer stem-cell model: clinical challenges and opportunities
Louis Vermeulen et al.
LANCET ONCOLOGY (2012)
Epigenetic therapy with 3-deazaneplanocin A, an inhibitor of the histone methyltransferase EZH2, inhibits growth of non-small cell lung cancer cells
Junko Kikuchi et al.
LUNG CANCER (2012)
EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
Michael T. McCabe et al.
NATURE (2012)
EPIGENETICS Stopping a chromatin enzyme
Jeffrey A. Simon
NATURE CHEMICAL BIOLOGY (2012)
Selective inhibition of Ezh2 by a small molecule inhibitor blocks tumor cells proliferation
Wei Qi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Role of BMI1, a Stem Cell Factor, in Cancer Recurrence and Chemoresistance: Preclinical and Clinical Evidences
Hifzur Rahman Siddique et al.
STEM CELLS (2012)
The histone methyltransferase inhibitor, DZNep, up-regulates TXNIP, increases ROS production, and targets leukemia cells in AML
Jianbiao Zhou et al.
BLOOD (2011)
S-adenosylhomocysteine hydrolase inhibition by 3-deazaneplanocin A analogues induces anti-cancer effects in breast cancer cell lines and synergy with both histone deacetylase and HER2 inhibition
Annette Hayden et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Long Noncoding RNA, Polycomb, and the Ghosts Haunting INK4b-ARF-INK4a Expression
Francesca Aguilo et al.
CANCER RESEARCH (2011)
(-)-Epigallocatechin-3-gallate and DZNep reduce polycomb protein level via a proteasome-dependent mechanism in skin cancer cells
Subhasree Roy Choudhury et al.
CARCINOGENESIS (2011)
Novel therapeutic Strategies for Targeting Liver Cancer Stem Cells
Naoki Oishi et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2011)
BMI1 As a Novel Target for Drug Discovery in Cancer
Liangxian Cao et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2011)
Epigenetic regulation of signaling pathways in cancer: Role of the histone methyltransferase EZH2
Daisy P. F. Tsang et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2011)
Interaction Proteomics Analysis of Polycomb Proteins Defines Distinct PRC1 Complexes in Mammalian Cells
Julien Vandamme et al.
MOLECULAR & CELLULAR PROTEOMICS (2011)
The Polycomb complex PRC2 and its mark in life
Raphael Margueron et al.
NATURE (2011)
Cholangiocarcinoma-controversies and challenges
Tushar Patel
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2011)
Overexpression of EZH2 and loss of expression of PTEN is associated with invasion, metastasis, and poor progression of gallbladder adenocarcinoma
Dong-Cai Liu et al.
PATHOLOGY RESEARCH AND PRACTICE (2011)
Roles of the Polycomb group proteins in stem cells and cancer
H. Richly et al.
CELL DEATH & DISEASE (2011)
Histone deacetylase inhibitor (SAHA) and repression of EZH2 synergistically inhibit proliferation of gallbladder carcinoma
Junpei Yamaguchi et al.
CANCER SCIENCE (2010)
Polycomb Group Proteins: Multi-Faceted Regulators of Somatic Stem Cells and Cancer
Martin Sauvageau et al.
CELL STEM CELL (2010)
Cholangiocarcinoma: New Insights into Disease Pathogenesis and Biology
Chiara Braconi et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2010)
Molecular Interplay of the Noncoding RNA ANRIL and Methylated Histone H3 Lysine 27 by Polycomb CBX7 in Transcriptional Silencing of INK4a
Kyoko L. Yap et al.
MOLECULAR CELL (2010)
Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis
Rajnish A. Gupta et al.
NATURE (2010)
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer.
Juan Valle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Polycomb Target Genes Are Silenced in Multiple Myeloma
Antonia Kalushkova et al.
PLOS ONE (2010)
Polycomb group protein-mediated repression of transcription
Lluis Morey et al.
TRENDS IN BIOCHEMICAL SCIENCES (2010)
Epidemiology of biliary tract cancers: an update
G. Randi et al.
ANNALS OF ONCOLOGY (2009)
Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells
Warren Fiskus et al.
BLOOD (2009)
Polycomb group protein Bmi1 is overexpressed and essential in anchorage-independent colony formation, cell proliferation and repression of cellular senescence in cholangiocarcinoma Tissue and culture studies
Motoko Sasaki et al.
HUMAN PATHOLOGY (2009)
Role of polycomb proteins Ring1A and Ring1B in the epigenetic regulation of gene expression
Miguel Vidal
INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY (2009)
The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells
Li-Bing Song et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
BMI1 Sustains Human Glioblastoma Multiforme Stem Cell Renewal
Mohamed Abdouh et al.
JOURNAL OF NEUROSCIENCE (2009)
The epigenetic regulators Bmi1 and Ring1B are differentially regulated in pancreatitis and pancreatic ductal adenocarcinoma
Carles Martinez-Romero et al.
JOURNAL OF PATHOLOGY (2009)
Papillary hyperplasia of the gallbladder in pancreaticobiliary maljunction represents a senescence-related lesion induced by lysolecithin
Junpei Yamaguchi et al.
LABORATORY INVESTIGATION (2009)
DZNep is a global histone methylation inhibitor that reactivates developmental genes not silenced by DNA methylation
Tina Branscombe Miranda et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression
Ahmad M. Khalil et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
BRCA1-deficient mammary tumor cells are dependent on EZH2 expression and sensitive to Polycomb Repressive Complex 2-inhibitor 3-deazaneplanocin A
Julian Puppe et al.
BREAST CANCER RESEARCH (2009)
Identification and characterization of ovarian cancer-initiating cells from primary human tumors
Shu Zhang et al.
CANCER RESEARCH (2008)
Prognostic value of Bmi-1 oncoprotein expression in NSCLC patients: a tissue microarray study
Katerina Vrzalikova et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2008)
Over-expression of polycomb group protein EZH2 relates to decreased expression of p16INK4a in cholangiocarcinogenesis in hepatolithiasis
M. Sasaki et al.
JOURNAL OF PATHOLOGY (2008)
Bmi-1 expression predicts prognosis for patients with gastric carcinoma
Jian-Hua Liu et al.
JOURNAL OF SURGICAL ONCOLOGY (2008)
The overexpression of polycomb group proteins Bmi1 and EZH2 is associated with the progression and aggressive biological behavior of hepatocellular carcinoma
Motoko Sasaki et al.
LABORATORY INVESTIGATION (2008)
The cancer stem cell hypothesis: in search of definitions, markers, and relevance
Michail Shipitsin et al.
LABORATORY INVESTIGATION (2008)
Ezh1 and Ezh2 Maintain Repressive Chromatin through Different Mechanisms
Raphael Margueron et al.
MOLECULAR CELL (2008)
Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation
Yutaka Kondo et al.
NATURE GENETICS (2008)
Stem cell protein BMI-1 is an independent marker for poor prognosis in oligodendroglial tumours
V. Hayry et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2008)
Increased polycomb-group oncogene Bmi-1 expression correlates with poor prognosis in hepatocellular carcinoma
Hui Wang et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2008)
Polycomb-group oncogenes EZH2, BMI1, and RING1 are overexpressed in prostate cancer with adverse pathologic and clinical features
Geert J. L. H. van Leenders et al.
EUROPEAN UROLOGY (2007)
Functional demarcation of active and silent chromatin domains in human HOX loci by Noncoding RNAs
John L. Rinn et al.
CELL (2007)
Pharmacologic disruption of polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells
Jing Tan et al.
GENES & DEVELOPMENT (2007)
The polycomb group protein Suz12 is required for embryonic stem cell differentiation
Diego Pasini et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells
Adrian P. Bracken et al.
GENES & DEVELOPMENT (2007)
Elevated Bmi-1 expression is associated with dysplastic cell transformation during oral carcinogenesis and is required for cancer cell replication and survival
M. K. Kang et al.
BRITISH JOURNAL OF CANCER (2007)
Bmi-1 is essential for the tumorigenicity of neuroblastoma cells
Hongjuan Cui et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Biliary intraepithelial neoplasia: an international interobserver agreement study and proposal for diagnostic criteria
Yoh Zen et al.
MODERN PATHOLOGY (2007)
Cholangiocarcinoma: Modern advances in understanding a deadly old disease
Harmeet Malhi et al.
JOURNAL OF HEPATOLOGY (2006)
Polycomb complexes repress developmental regulators in murine embryonic stem cells
LA Boyer et al.
NATURE (2006)
Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions
AP Bracken et al.
GENES & DEVELOPMENT (2006)
The Polycomb group protein EZH2 directly controls DNA methylation
E Viré et al.
NATURE (2006)
Cholangiocarcinoma
T Patel
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY (2006)
Role of Bmi-1 and Ring1A in H2A ubiquitylation and Hox gene silencing
R Cao et al.
MOLECULAR CELL (2005)
Association of BMI1 with polycomb bodies is dynamic and requires PRC2/EZH2 and the maintenance DNA methyltransferase DNMT1
I Hernández-Muñoz et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Down-regulation of human DAB2IP gene expression mediated by polycomb Ezh2 complex and histone deacetylase in prostate cancer
H Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Bmi1, stem cells, and senescence regulation
IK Park et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Epigenetics in human disease and prospects for epigenetic therapy
G Egger et al.
NATURE (2004)
EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer
AP Bracken et al.
EMBO JOURNAL (2003)
Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells
J Lessard et al.
NATURE (2003)
Rnf2 (Ring1b) deficiency causes gastrulation arrest and cell cycle inhibition
JW Voncken et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste protein
A Kuzmichev et al.
GENES & DEVELOPMENT (2002)
Role of histone H3 lysine 27 methylation in polycomb-group silencing
R Cao et al.
SCIENCE (2002)
Share Paper
